Cargando…
Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer
Blood testing for circulating tumour cells (CTC) has emerged as one of the hottest fields in cancer research. CTC detection and enumeration can serve as a ‘liquid biopsy' and an early marker of response to systemic therapy, whereas their molecular characterisation has a strong potential to be t...
Autores principales: | Lianidou, E S, Mavroudis, D, Georgoulias, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694246/ https://www.ncbi.nlm.nih.gov/pubmed/23756869 http://dx.doi.org/10.1038/bjc.2013.265 |
Ejemplares similares
-
Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting
por: Strati, Areti, et al.
Publicado: (2023) -
The measurement and therapeutic implications of circulating tumour cells in breast cancer
por: Smerage, J B, et al.
Publicado: (2006) -
Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017) -
Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR
por: Strati, Areti, et al.
Publicado: (2011) -
Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)